Skip to content

Investor Calendar

Investor Calendar

The information herein is intended to be considered in the context of Ashland's SEC filings and other public announcements that Ashland may make from time to time.

Ashland's news releases, speeches or presentations contained here are for historical purposes only. As further described in the Terms of Use of Ashland's website, statements regarding Ashland's businesses that are not historical facts are "forward-looking statements" that involve risks and uncertainties and may no longer be accurate. Ashland has no obligation to update any information contained in such releases, speeches or presentations. For a discussion of such risks and uncertainties, see Risk Factors in Ashland's most recent Form 10-K and subsequent Form 10-Q filings.

Upcoming Events
More events are coming soon.


Archived Events

Date Event Details
Summary Toggle 11/11/2020 9:00 AM EST
Summary Toggle 07/29/2020 9:00 AM EDT
Summary Toggle 05/06/2020 10:00 AM EDT
Summary Toggle 01/28/2020 9:00 AM EST

1st Quarter 2020 Earnings Call

Summary Toggle 11/19/2019 9:00 AM EST
Summary Toggle 07/31/2019 10:00 AM EDT
Summary Toggle 05/01/2019 9:00 AM EDT
Summary Toggle 02/06/2019 9:00 AM EST
Summary Toggle 11/07/2018 9:00 AM EST
Summary Toggle 08/01/2018 9:00 AM EDT
Summary Toggle 05/02/2018 9:00 AM EDT
Summary Toggle 01/30/2018 9:00 AM EST
Summary Toggle 11/07/2017 9:00 AM EST
Summary Toggle 08/02/2017 9:00 AM EDT
Summary Toggle 05/01/2017 from 8:30 AM to 12:00 PM EDT

Ashland Investor Day

Supporting Materials

Summary Toggle 04/26/2017 9:00 AM EDT
Summary Toggle 04/17/2017

Slide presentation: Ashland to acquire Pharmachem Laboratories, Inc.

Summary Toggle 01/27/2017 9:00 AM EST
Summary Toggle 11/09/2016 9:00 AM EST
Summary Toggle 07/27/2016 9:00 AM EDT
Summary Toggle 04/27/2016 9:00 AM EDT
Summary Toggle 01/26/2016 9:00 AM EST
Summary Toggle 11/11/2015 8:30 AM EST

Ashland Analyst Day

Supporting Materials

Summary Toggle 11/04/2015 9:00 AM EST
Summary Toggle 09/22/2015 9:00 AM EDT

Ashland Inc. Special Call

Supporting Materials

Summary Toggle 07/30/2015 9:00 AM EDT
Summary Toggle 04/30/2015 9:00 AM EDT
Summary Toggle 01/27/2015 10:00 AM EST
Summary Toggle 11/06/2014 9:00 AM EST
Summary Toggle 08/01/2014 9:00 AM EDT
Summary Toggle 05/01/2014 9:00 AM EDT

Forward-Looking Statements
This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as “anticipates,” “believes,” “expects,” “estimates,” “is likely,” “predicts,” “projects,” “forecasts,” “objectives,” “may,” “will,” “should,” “plans” and “intends” and the negative of these words or other comparable terminology. Ashland may from time to time make forward-looking statements in its annual reports, quarterly reports and other filings with the SEC, news releases and other written and oral communications. These forward-looking statements are based on Ashland’s expectations and assumptions, as of the date such statements are made, regarding Ashland’s future operating performance and financial condition, as well as the economy and other future events or circumstances. These statements include, but may not be limited to, Ashland’s assessment on its progress towards becoming a premiere specialty chemicals company and its expectations regarding its ability to drive sales and earnings growth, realize further cost reductions and complete the anticipated divestiture of its Composites business and Marl BDO facility. Ashland’s expectations and assumptions include, without limitation, internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, operating efficiencies and economic conditions (such as prices, supply and demand, cost of raw materials, and the ability to recover raw-material cost increases through price increases), and risks and uncertainties associated with the following: the program to eliminate certain existing corporate and Specialty Ingredients expenses (including the possibility that such cost eliminations may not occur or may take longer to implement than anticipated), the expected divestiture of its Composites segment and the Marl BDO facility, and related merchant I&S products (including, in each case, the possibility that a transaction may not occur or that, if a transaction does occur, Ashland may not realize the anticipated benefits from such transaction), the impact of acquisitions and/or divestitures Ashland has made or may make, including the acquisition of Pharmachem (including the possibility that Ashland may not realize the anticipated benefits from such transactions); Ashland’s substantial indebtedness (including the possibility that such indebtedness and related restrictive covenants may adversely affect Ashland’s future cash flows, results of operations, financial condition and its ability to repay debt); Ashland’s ability to generate sufficient cash to finance its stock repurchase plans; severe weather, natural disasters, cyber events and legal proceedings and claims (including product recalls, environmental and asbestos matters); and without limitation, risks and uncertainties affecting Ashland that are described in Ashland’s most recent Form 10-K (including Item 1A Risk Factors) filed with the SEC, which is available on Ashland’s website at or on the SEC’s website at Various risks and uncertainties may cause actual results to differ materially from those stated, projected or implied by any forward-looking statements. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Unless legally required, Ashland undertakes no obligation to update any forward-looking statements made in this communication whether as a result of new information, future events or otherwise.

Important Information
In connection with the forthcoming solicitation of proxies from stockholders in respect of Ashland’s 2019 Annual Meeting of Stockholders, Ashland will file with the Securities and Exchange Commission (“SEC”) a proxy statement on Schedule 14A (the “proxy statement”), containing a form of white proxy card. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ ALL RELEVANT DOCUMENTS, INCLUDING ASHLAND’S PROXY STATEMENT AND ANY AMENDMENTS THERETO AND ACCOMPANYING WHITE PROXY CARD, FILED WITH OR FURNISHED TO THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN, OR WILL CONTAIN, IMPORTANT INFORMATION ABOUT ASHLAND.

Certain Information Regarding Participants
Ashland, its directors and certain of its executive officers, including William A. Wulfsohn, Brendan Cummins, William G. Dempsey, Jay V. Ihlenfeld, Susan L. Main, Jerome A. Peribere, Barry W. Perry, Mark C. Rohr, Janice J. Teal, Michael J. Ward, Kathleen Wilson-Thompson, Kevin J. Willis, Peter J. Ganz and Seth A. Mrozek, will be participants in the solicitation of proxies from stockholders in respect of the 2019 Annual Meeting of Stockholders. Information regarding the ownership of the Company’s directors and executive officers in the company by security holdings or otherwise is included in Ashland’s Annual Report on Form 10-K for the year ended September 30, 2017, which was filed with the SEC on November 20, 2017, and its proxy statement for the 2018 Annual Meeting of Stockholders, which was filed with the SEC on December 6, 2017. To the extent holdings of Ashland securities have changed since the amounts printed in the proxy statement for the 2018 Annual Meeting, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Details concerning the nominees of Ashland’s Board of Directors for election at the 2019 Annual Meeting will be included in the proxy statement when it is filed by Ashland with the SEC. Stockholders may obtain free copies of the proxy statement and other relevant documents that Ashland files with the SEC on Ashland’s website at or from the SEC’s website at